Associations between tobacco, alcohol, and drug use with coronary artery plaque among HIV-infected and uninfected men in the multicenter AIDS cohort study

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Kelly, Sean G ^a   Plankey, Michael ^b   Post, Wendy S ^c,d   Li, Xiuhong ^d   Stall, Ronald ^e   Jacobson, Lisa P ^d   Witt, Mallory D ^f   Kingsley, Lawrence ^e   Cox, Christopher ^d   Budoff, Matthew ^f   Palella, Frank J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^f HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECREATIONAL DRUG;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY CALCIUM SCORE; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY PLAQUE; DISEASE ASSOCIATION; DRUG USE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; MULTICENTER AIDS COHORT STUDY; SMOKING; SMOKING CESSATION; SMOKING HABIT; TOBACCO; ATHEROSCLEROTIC PLAQUE; COMPLICATION; CORONARY ANGIOGRAPHY; DRINKING BEHAVIOR; DRUG DEPENDENCE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; X-RAY COMPUTED TOMOGRAPHY;

ALCOHOL DRINKING; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; HIV INFECTIONS; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PLAQUE, ATHEROSCLEROTIC; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING; SUBSTANCE-RELATED DISORDERS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84958559351     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0147822     Document Type: Article

References (53)

1. Palella F, Delaney K, Moorman A, Loveless M, Fuhrer J, Satten G, et al. Declining morbidity and mortality in an ambulatory HIV-infected population. N Engl J Med. 1998; 338:853-60. PMID: 9516219
2. Hakeem A, Bhatti S, Cilingiroglu M. The spectrum of atherosclerotic coronary artery disease in HIV patients. Curr Atheroscler Rep. 2010; 12(2):119-24. doi: 10.1007/s11883-010-0089-4 PMID: 20425247
3. Bergersen BM, Sandvik L, Bruun JN, Tonstad S. Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjects. Eur J Clin Microbiol Infect Dis. 2004; 23(8):625-30. PMID: 15322938
4. D'Abramo A, D'Agostino C, Oliva A, Iannetta M, D'Ettorre G, Vullo F, et al. Early Atherosclerosis in HIV Infected Subjects on Suppressive Antiretroviral Treatment: Role of Osteoprotegerin. ISRN AIDS. 2013;2013.
5. Lo J, Abbara S, Shturman L, Soni A, Wei J, Rocha-Filho JA, et al. Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men. AIDS. 2010; 24(2):243-53. doi: 10.1097/QAD.0b013e328333ea9e PMID: 19996940
6. Lai S, Bartlett J, Lai H, Moore R, Cofrancesco J Jr, Pannu H, et al. Long-term combination antiretroviral therapy is associated with the risk of coronary plaques in African Americans with HIV infection. AIDS Patient Care STDS. 2003; 23(10):815-24.
7. Shrestha S, Irvin MR, Grunfeld C, Arnett DK. HIV, Inflammation, and Calcium in Atherosclerosis. Arterioscler Thromb Vasc Biol. 2014; 34(2):244-50. doi: 10.1161/ATVBAHA.113.302191 PMID: 24265418
8. Farrugia PM, Lucariello R, Coppola JT. Human immunodeficiency virus and atherosclerosis. Cardiol Rev. 2009; 17(5):211-5. doi: 10.1097/CRD.0b013e3181b151a3 PMID: 19690471
9. Albuquerque VM, Zírpoli JC, de Barros Miranda-Filho D, Albuquerque Mde F, Montarroyos UR, de Alencar Ximenes RA, et al. Risk factors for subclinical atherosclerosis in HIV-infected patients under and over 40 years: a case-control study. BMC Infect Dis. 2013; 13:274 doi: 10.1186/1471-2334-13-274 PMID: 23773229
10. Maggi P, Quirino T, Ricci E, De Socio GV, Gadaleta A, Ingrassia F, et al. Cardiovascular risk assessment in antiretroviral-naïve HIV patients. AIDS Patient Care STDS. 2009; 23(10):809-13. doi: 10.1089/apc.2009.0102 PMID: 19824809
11. Robinson FP, Hoff JA, Kondos GT. Coronary artery calcium in HIV-infected men treated with highly active antiretroviral therapy. J Cardiovasc Nurs. 2005; 20(3):149-54. PMID: 15870584
12. Post WS, Budoff M, Kingsley L, Palella FJ, Witt MD, Li X, et al. Associations between HIV infection and subclinical coronary atherosclerosis. Ann Intern Med. 2014; 160(7):458-67. doi: 10.7326/M13-1754 PMID: 24687069
13. Ahmadi N, Nabavi V, Hajsadeghi F, Flores F, French WJ, et al. Mortality incidence of patients with nonobstructive coronary artery disease diagnosed by computed tomography angiography. Am J Cardiol. 2011; 107: 10-16. doi: 10.1016/j.amjcard.2010.08.034 PMID: 21146679
14. Zanni MV, Fitch KV, Feldpausch M, Han A, Lee H, et al. 2013 American College of Cardiology/American Heart Association and 2004 Adult Treatment Panel III cholesterol guidelines applied to HIVinfected patients with/without subclinical high-risk coronary plaque. AIDS. 2014; 28: 2061-2070. doi: 10.1097/QAD.0000000000000360 PMID: 25265074
15. Ebersberger U, Sudarski S, Schoepf UJ, Bamberg F, Tricarico F, Apfaltrer P, et al. Atherosclerotic plaque burden in cocaine users with acute chest pain: analysis by coronary computed tomography angiography. Atherosclerosis. 2013; 229(2):443-8. doi: 10.1016/j.atherosclerosis.2013.05.032 PMID: 23880201
16. Benzaquen BS, Cohen V, Eisenberg MJ. Effects of cocaine on the coronary arteries. Am Heart J. 2001; 142(3):402-10. PMID: 11526352
17. Yankelevitz DF, Henschke CI, Yip R, Boffetta P, Shemesh J, Cham MD, et al. Second-hand tobacco smoke in never smokers is a significant risk factor for coronary artery calcification. JACC Cardiovasc Imaging. 2013; 6(6):651-7. doi: 10.1016/j.jcmg.2013.02.004 PMID: 23490845
18. Mukamal KJ, Maclure M, Muller JE, Mittleman MA. An exploratory prospective study of marijuana use and mortality following acute myocardial infarction. Am Heart J. 2008; 155(3):465-70. doi: 10.1016/j. ahj.2007.10.049 PMID: 18294478
19. Mittleman MA, Lewis RA, Maclure M, Sherwood JB, Muller JE. Triggering myocardial infarction by marijuana. Circulation. 2001; 103(23):2805-9. PMID: 11401936
20. Karch SB, Stephens BG, Ho CH. Methamphetamine-related deaths in San Francisco: demographic, pathologic, and toxicologic profiles. J Forensic Sci. 1999; 44(2):359-68. PMID: 10097363
21. The NSDUH Report: HIV/AIDS and Substance Use Rockville, MD2010 [updated 12/1/2010; cited 2014 2/14/14]. Available from: http://www.samhsa.gov/data/2k10/HIV-AIDS/HIV-AIDs.htm.
22. Sullivan PS, Nakashima AK, Purcell DW, Ward JW, and the Supplement to the HIV/AIDS Surveillance Study Group. Geographic differences in noninjection and injection substance use among HIV-seropositive men who have sex with men: western United States versus other regions. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 19:266-73. PMID: 9803969
23. Lai S, Lai H, Meng Q, Tong W, Vlahov D, Celentano D, Strathdee S, Nelson K, Fishman EK, Lima JAC Effect of cocaine use on coronary calcification among black adults in Baltimore. Am J Cardiol. 2002; 90:326-8. PMID: 12127624
24. Meng Q, Lima JA, Lai H, Vlahov D, Celentano DD, Margolick JB, Lai S. Elevated C-reactive protein levels are associated with endothelial dysfunction in chronic cocaine users. Int J Cardiol. 2003; 88:191-8. PMID: 12714198
25. Tai H, Lai H, Jani J, Lai S, Kickler TS. HIV infection and cocaine use induce endothelial damage and dysfunction in African Americans. Int J Cardiol. 2012; 161(2):83-7. doi: 10.1016/j.ijcard.2011.04.034 PMID: 21600668
26. Mosunjac MI, Sundstrom JB, Heninger M, Ansari AA, Mosunjac MB. Combined pathological effects of cocaine abuse and HIV infection on the cardiovascular system: an autopsy study of 187 cases from the Fulton County Medical Examiner's office. Am J Forensic Med Pathol. 2008; 29(1):9-13. doi: 10.1097/PAF.0b013e318165152f PMID: 19749609
27. Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, Rinaldo CR Jr. The multicenter AIDS cohort study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol. 1987; 126:310-8. PMID: 3300281
28. Dudley J, Jin S, Hoover D, Metz S, Thackeray R, Chmiel J. The Multicenter AIDS Cohort Study: retention after 9 1/2 years. American journal of epidemiology. 1995; 142(3):323-30. PMID: 7631636
29. Hultin LE, Menendez FA, Hultin PM, Jamieson BD, O'Gorman MR, Borowski L, Matud JL, Denny TN, Margolick JB. Assessing immunophenotyping performance: proficiency-validation for adopting improved flow cytometry methods. Cytometry B Clin Cytom. 2007; 72(4):249-55. PMID: 17205569
30. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992; 41(RR-17):1-19. PMID: 1361652
31. Brennan-Ing M, Porter KE, Seidel L, Karpiak SE. Substance use and sexual risk differences among older bisexual and gay men with HIV. Behav Med; 2014; 40: 108-115. doi: 10.1080/08964289.2014. 889069 PMID: 25090363
32. Hacioglu Y, Gupta M, Choi T-Y, George RT, Deible CR, Jacobson L, et al. Use of Cardiact CT Angiography Imaging in an Epidemiology Study - the Methodology of the Multicenter AIDS Cohort Study Cardiovascular Disease Substudy. Anadolu Kardiyol Derg. 2013; 13(3):207-14. doi: 10.5152/akd.2013. 065 PMID: 23376648
33. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, et al. A reporting system on patients evaluated for coronary artery disease. Report of the ad hoc committee for grading of coronary artery disease, council on cardiovascular surgery, American Heart Association. Circulation. 1975; 51:5-40. PMID: 1116248
34. Schafer JL. Analysis of incomplete multivariate data. London: Chapman and Hall; 1997.
35. Webb MS, Vanable PA, Carey MP, Blair DC. Cigarette smoking among HIV+ men and women: examining health, substance use, and psychosocial correlates across the smoking spectrum. J Behav Med. 2007; 30(5):371-83. PMID: 17570050
36. Lifson AR, Neuhaus J, Arribas JR, van den Berg-Wolf M, Labriola AM, Read TR; INSIGHT SMART Study Group. Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial. Am J Public Health. 2010; 100(10):1896-903. doi: 10.2105/AJPH. 2009.188664 PMID: 20724677
37. Leone A. Interactive effect of combined exposure to active and passive smoking on cardiovascular system. Recent Pat Cardiovasc Drug Discov. 2011; 6(1):61-9. PMID: 21222651
38. Motoyama S, Kondo T, Sarai M, Sugiura A, Harigaya H, Sato T, et al. Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. J Am Coll Cardiol. 2007; 50:319-26. PMID: 17659199
39. Lloyd-Richardson EE, Stanton CA, Papandonatos GD, Shadel WG, Stein M, Tashima K, et al. Motivation and patch treatment for HIV+ smokers: a randomized controlled trial. Addiction. 2009; 104 (11):1891-900. doi: 10.1111/j.1360-0443.2009.02623.x PMID: 19719796
40. Matthews AK, Conrad M, Kuhns L, Vargas M, King AC. Project Exhale: preliminary evaluation of a tailored smoking cessation treatment for HIV-positive African American smokers. AIDS Patient Care STDS. 2013; 27(1):22-32. doi: 10.1089/apc.2012.0253 PMID: 23305259
41. Moadel AB, Bernstein SL, Mermelstein RJ, Arnsten JH, Dolce EH, Shuter J. A randomized controlled trial of a tailored group smoking cessation intervention for HIV-infected smokers. J Acquir Immune Defic Syndr Hum Retrovirol. 2012; 61(2):208-15.
42. Cummins D, Trotter G, Moussa M, Turham G. Smoking cessation for clients who are HIV-positive. Nurs Stand. 2005; 20:41-7.
43. Roussillon C, Beuscart A, Chene G, Ferret S, Mercie P, Katlama C, et al. Varenicline vs Placebo for Smoking Cessation: ANRS 144 Inter-ACTIV Randomized Trial. Conference on Retroviruses and Opportunistic Infections; 2015 February 23-26; Seattle, WA.
44. Burkhalter JE, Springer CM, Chhabra R, Ostroff JS, Rapkin BD. Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine Tob Res. 2005; 7(4):511-22. PMID: 16085522
45. Chew D, Steinberg MB, Thomas P, Swaminathan S, Hodder SL. Evaluation of a Smoking Cessation Program for HIV Infected Individuals in an Urban HIV Clinic: Challenges and Lessons Learned. AIDS Res Treat. 2014; 2014:237834. doi: 10.1155/2014/237834 PMID: 25349726
46. Mukamal KJ, Chiuve SE, Rimm EB. Alcohol consumption and risk for coronary heart disease in men with healthy lifestyles. Arch Intern Med. 2006; 166(19):2145-50. PMID: 17060546
47. Thun MJ, Peto R, Lopez AD, Monaco JH, Henley SJ, Heath CW Jr, et al. Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med 1997; 337(24):1705-14. PMID: 9392695
48. Mukamal KJ, Chen CM, Rao SR, Breslow RA. Alcohol consumption and cardiovascular mortality among U.S. adults, 1987 to 2002. J Am Coll Cardiol. 2010; 55(13):1328-35. doi: 10.1016/j.jacc.2009. 10.056 PMID: 20338493
49. Tolstrup J, Jensen MK, Tjønneland A, Overvad K, Mukamal KJ, Grønbaek M. Prospective study of alcohol drinking patterns and coronary heart disease in women and men. BMJ. 2006; 332(7552):1244-8. PMID: 16672312
50. Mukamal KJ, Conigrave KM, Mittleman MA, Camargo CA Jr, Stampfer MJ, Willett WC, et al. Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med. 2003; 348(2):109-18. PMID: 12519921
51. González-Reimers E, Santolaria-Fernández F, Martín-González MC, Fernández-Rodríguez CM, Quintero-Platt G. Alcoholism: A systemic proinflammatory condition. World J Gastroenterol. 2014; 20 (40):14660-71. doi: 10.3748/wjg.v20.i40.14660 PMID: 25356029
52. Pletcher MJ, Varosy P, Kiefe CI, Lewis CE, Sidney S, Hulley SB. Alcohol consumption, binge drinking, and early coronary calcification: findings from the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Epidemiol 2005; 161(5):423-33. PMID: 15718478
53. Mukamal KJ, Cushman M, Mittleman MA, Tracy RP, Siscovick DS. Alcohol consumption and inflammatory markers in older adults: the Cardiovascular Health Study. Atherosclerosis. 2004; 173(1):79-87. PMID: 15177126